CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Mixed amphetamine salts

Last Updated: November 29, 2007
Result type: Reports
Project Number: S0116
Product Line: Common Drug Review

Generic Name: Mixed amphetamine salts

Brand Name: Adderall XR

Manufacturer: Shire Canada Inc.

Indications: Attention deficit hyperactivity disorder, Adult

Submission Type: New Indication

Project Status: Complete

Date Recommendation Issued: June 25, 2008

Recommendation Type: Do not list